Two Sigma Investments, LP Precigen, Inc. Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Precigen, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 43,159 shares of PGEN stock, worth $28,916. This represents 0.0% of its overall portfolio holdings.

Number of Shares

43,159

Previous 48,315 10.67%

Holding current value

$28,916

Previous $76,000 46.05%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.91 - $1.88 $4,691 - $9,693	-5,156 Reduced 10.67%	43,159 $41,000
Q2 2024 Aug 14, 2024	SELL	$1.27 - $1.75 $20,239 - $27,889	-15,937 Reduced 24.8%	48,315 $76,000
Q1 2024 May 15, 2024	SELL	$1.21 - $1.75 $35,753 - $51,709	-29,548 Reduced 31.5%	64,252 $93,000
Q4 2023 Feb 14, 2024	SELL	$0.89 - $1.41 $9,078 - $14,382	-10,200 Reduced 9.81%	93,800 $125,000
Q2 2023 Aug 14, 2023	SELL	$0.96 - $1.4 $81,120 - $118,299	-84,500 Reduced 44.83%	104,000 $119,000
Q1 2023 May 15, 2023	BUY	$0.88 - $2.19 $52,551 - $130,782	59,718 Added 46.37%	188,500 $199,000
Q4 2022 Feb 14, 2023	SELL	$1.27 - $2.26 $285,687 - $508,389	-224,951 Reduced 63.59%	128,782 $195,000
Q3 2022 Nov 14, 2022	SELL	$1.41 - $2.79 $291,463 - $576,726	-206,712 Reduced 36.88%	353,733 $750,000
Q2 2022 Aug 15, 2022	SELL	$1.15 - $2.53 $711,312 - $1.56 Million	-618,533 Reduced 52.46%	560,445 $751,000
Q1 2022 May 16, 2022	BUY	$1.91 - $3.98 $1.4 Million - $2.92 Million	733,141 Added 164.44%	1,178,978 $2.49 Million
Q4 2021 Feb 14, 2022	BUY	$3.53 - $5.5 $1.03 Million - $1.61 Million	291,917 Added 189.66%	445,837 $1.65 Million
Q3 2021 Nov 15, 2021	BUY	$4.99 - $6.55 $52,419 - $68,807	10,505 Added 7.32%	153,920 $768,000
Q2 2021 Aug 16, 2021	SELL	$6.24 - $8.22 $1.65 Million - $2.18 Million	-264,870 Reduced 64.87%	143,415 $935,000
Q1 2021 May 17, 2021	BUY	$6.74 - $10.95 $2.33 Million - $3.78 Million	345,152 Added 546.71%	408,285 $2.81 Million
Q4 2020 Feb 16, 2021	BUY	$3.75 - $10.56 $80,625 - $227,040	21,500 Added 51.64%	63,133 $644,000
Q3 2020 Nov 16, 2020	SELL	$3.5 - $6.2 $70,539 - $124,954	-20,154 Reduced 32.62%	41,633 $146,000
Q2 2020 Aug 14, 2020	SELL	$2.16 - $5.46 $22,833 - $57,717	-10,571 Reduced 14.61%	61,787 $308,000
Q1 2020 May 15, 2020	BUY	$1.46 - $7.19 $105,642 - $520,254	72,358 New	72,358 $246,000

Others Institutions Holding PGEN

# of Institutions

143

Shares Held

159M

Call Options Held

232K

Put Options Held

69K

View Full List

About PRECIGEN, INC.

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $139M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

More about PGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Precigen, Inc. Transaction History